ViiV Healthcare (GSK) Director/Toxicology Project Specialist
ViiV Healthcare
Summary
As the Director/Toxicology Project Specialist, you will be responsible for developing the end-to-end non-clinical safety strategy for projects across ViiV Healthcare's portfolio. You will work in a highly matrixed global environment and collaborate extensively to evolve non-clinical safety strategies based on input from market research, competitive intelligence, and learnings from internal programs. You will also work to integrate non-clinical project plans with CMC, regulatory, and clinical plans to optimize speed of drug development.
Job description
Responsibilities
- Toxicology project team member (PTM) supporting 5-10 projects at any given time
- Sufficient breadth of knowledge of all areas of NCS (and supportive processes) to strategically and efficiently drive aspects of projects in discovery and/or development phases, including provision for external diligence activities
- Has a good knowledge of other disciplines (e.g. Pharmacology, DMPK, Clinical, etc.) to enable visible contributions to a multi-disciplinary scientific/operational strategy
- Sustained ability to support multiple projects across various modalities, including small molecules, biologics and alternative platforms
- Proven competency to integrate data and craft clear and appropriate narratives for internal governance decision reviews e.g., technical/investment boards, and/or regulatory documentation (IB/IND/NDA/BLA)
- Proven excellent communicator (both written and verbal skills) which supports the capability to positively influencing external stakeholders, e.g. regulators (at a project level) or senior leaders in ViiV/GSK
- Coaches/mentors other project team members and is highly regarded as a reviewer/approver of regulatory and or internal milestone documents
- Sustained record of highly effective teamwork leveraging SMEs as required, providing clear and regular line of sight and leadership to project issues and progression challenges
- Leadership of major scientific or technical initiatives within and external to the Pre-clinical Sciences team
- Record of flexible, creative and courageous thinking, providing multiple options to project teams, EDLs/MDLs, etc.
- Ability to effectively prioritise multiple and conflicting objectives and evidence of learning agility
- Collaborate internally with GSK pre-clinical sciences organization and externally with academic institutions to leverage and enhance scientific capabilities
- Participate on due diligence teams in the integrated scientific/technical evaluation of external opportunities
- Contribute to consultancy on drug disposition, pre-clinical safety and on-target and off-target engagement/modulation on request, including support for marketed products, as needed
- Contribute to training and mentoring of other toxicologists, as appropriate
- Participate in internal and external committees and panels as assigned by the team leader
Basic Qualifications
- Master's degree with 8+ years, or PhD with 6+ years, of experience in non-clinical safety/toxicology
- Experience as a project team member covering a number of projects across a broad range of stages in development and across all modalities, including biologics
- Non-clinical Safety capability and experience coupled with an understanding of the interrelationships between disposition, safety and on/off target engagement as applied to the identification and articulation of critical needs and deliverables for projects
- Knowledge and experience of the Non-clinical Safety aspects of worldwide regulatory requirements for drug development and registration
Preferred Qualifications
- Experience in non-clinical discovery and development of long-acting small molecules
- DABT (Diplomat of American Board of Toxicology)
- Experience in infectious disease therapy area
- May be a recognized leader in a specific scientific field or discipline of interest, maintaining an extensive network (with a publication record) in that specific scientific field
Requirements
- Master's degree with 8+ years, or PhD with 6+ years, of experience in non-clinical safety/toxicology
- Experience as a project team member covering a number of projects across a broad range of stages in development and across all modalities, including biologics
- Non-clinical Safety capability and experience coupled with an understanding of the interrelationships between disposition, safety and on/off target engagement
- Knowledge and experience of the Non-clinical Safety aspects of worldwide regulatory requirements for drug development and registration
- Experience in non-clinical discovery and development of long-acting small molecules
- DABT (Diplomat of American Board of Toxicology)
- Experience in infectious disease therapy area
Benefits
- Health care
- Insurance benefits
- Retirement benefits
- Paid holidays
- Vacation
- Paid caregiver leave
- Paid parental leave
- Paid medical leave
- Annual bonus
- Share based long term incentive program
Company overview
ViiV Healthcare is a British multinational pharmaceutical company exclusively dedicated to the research, development, and commercialization of medicines for the treatment and prevention of HIV/AIDS. Established in 2009 as a joint venture between GSK and Pfizer, with Shionogi joining in 2012, ViiV Healthcare represents a unique collaboration in the pharmaceutical industry with ownership distributed among GSK (76.5%), Pfizer (13.5%), and Shionogi (10%). As the only global pharmaceutical company 100% focused on HIV, ViiV Healthcare has developed a comprehensive portfolio of antiretroviral therapies including nucleoside reverse transcriptase inhibitors, integrase strand transfer inhibitors, protease inhibitors, and innovative fixed-dose combinations. The company holds approximately 32% of the global HIV therapy market, making it the second-largest player in this specialized sector. With over 1,100 employees worldwide and headquarters in London, ViiV Healthcare operates across multiple continents, maintaining a strong commitment to community engagement, treatment access programs, and partnerships with HIV-affected communities to advance its mission of ending the HIV epidemic.